HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Patrick Trucchio has reiterated a Buy rating on Gossamer Bio (NASDAQ:GOSS) and maintained a $10 price target.
May 06, 2024 | 4:16 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. reaffirms a Buy rating on Gossamer Bio with a $10 price target, indicating a positive outlook on the stock.
The reiteration of a Buy rating and maintenance of a $10 price target by a reputable analyst firm like HC Wainwright & Co. suggests a strong belief in Gossamer Bio's potential for growth. This endorsement could positively influence investor sentiment and potentially drive up the stock price in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100